Evidence map›Paper›PMID 35620276›Full record

ArticleGalen medical journal2021

The Fasa Registry on Systolic Heart Failure (FaRSH): Feasibility Study and the First 5-year Reports.

Mohammad Hosein Yazdanpanah, Ehsan Bahramali, Maryam Kazemi, Negar Firouzabadi, Peyman Arasteh, Reza Homayounfar, Alireza Sepehri Shamloo, Mojtaba Farjam

Open access · greenAbstract read
In one paragraph

Article in Galen medical journal, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.3field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Mohammad Hosein YazdanpanahStudent Research Committee, Fasa University of Medical Sciences, Fasa, Iran.
Ehsan BahramaliNon-communicable Diseases Research Center, Fasa University of Medical Sciences, Fasa, Iran.
Maryam KazemiDepartment of Community and Preventive Medicine, Fasa University of Medical Sciences, Fasa, Iran.
Negar FirouzabadiDepartment of Pharmacology and Toxicology, School of Pharmacy, Shiraz University of Medical Sciences, Shiraz, Iran.
Peyman ArastehNon-communicable Diseases Research Center, Fasa University of Medical Sciences, Fasa, Iran.
Reza HomayounfarNon-communicable Diseases Research Center, Fasa University of Medical Sciences, Fasa, Iran.
Alireza Sepehri ShamlooDepartment of Electrophysiology, Heart Center Leipzig at University of Leipzig, Germany.
Mojtaba FarjamNon-communicable Diseases Research Center, Fasa University of Medical Sciences, Fasa, Iran.
Fasa University of Medical Sciences · IRShiraz University of Medical Sciences · IRTehran University of Medical Sciences · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: The literature on patients with heart failure (HF) from the Middle East, besides a few existing registries, is scarce. We report, for the first time in our country, a hospital-based registry for systolic HF. Materials and Methods: This was a web-based registry on HF, conducted in Vali-Asr Hospital affiliated with Fasa University of Medical Sciences, Fasa, Iran. The goal of this registry was to define overall baseline clinical characteristics and natural history of hospitalized patients with systolic HF, to evaluate current management schema and implementation of practice guidelines, and to determine the correlation between genetic predisposition environmental effects, individuals' characteristics of health, lifestyle, morbidity, and mortality in relation with the effects of medication. Results: To date, 2378 individuals with a mean of age 67.08±13.07 years have been registered. Among which, 1381 (58.07%) patients were diagnosed with denovo HF. Most of the patients (60.1%) were male, and 8.9% had admissions during the past 30 days. The most common causes of HF were ischemic heart disease (86.5%) and hypertension (5.3%). Most patients had NYHA class one (44.3%) and three (20.4%). Overall, near 30% had diabetes and more than 38% had hyperlipidemia. Most individuals have been not a history of cigarette smoking (68.7%) or water-pipe smoking (96.9%). Also, 22.2% were current opium users, and 3.2% were previous opium users. Conclusion: The findings of this registry could make a realistic view of HF as a chronic disease with a burden. Therefore, policymakers can design programs and guidelines to prevent disease and better survival and quality of life.

Indexed as

Heart FailureIranRegistrySystolic

Identifiers

PMID35620276
PMCPMC9107350
OpenAlexW4285746820

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.